• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保守治疗的前庭神经鞘瘤的肿瘤生长及听力测定变化

Tumor growth and audiometric change in vestibular schwannomas managed conservatively.

作者信息

Massick D D, Welling D B, Dodson E E, Scholfield M, Nagaraja H N, Schmalbrock P, Chakeres D W

机构信息

Department of Otolaryngology, The Ohio State University, Columbus 43210, USA.

出版信息

Laryngoscope. 2000 Nov;110(11):1843-9. doi: 10.1097/00005537-200011000-00015.

DOI:10.1097/00005537-200011000-00015
PMID:11081597
Abstract

OBJECTIVE

To prospectively define the correlation between changes in tumor volume and audiometric function in vestibular schwannomas managed conservatively.

STUDY DESIGN

Prospective longitudinal study.

METHODS

Twenty-one patients (age range, 15-84 y; mean age, 63.3 y) with newly diagnosed vestibular schwannomas were enrolled between 1994 and 1999 in a protocol at The Ohio State University Hospital (Columbus, OH) to evaluate the correlation between tumor volume and audiometric change during a period of observation. Patients were evaluated yearly by clinical examination, a standardized internal auditory canal magnetic resonance imaging scan with gadolinium contrast for volumetric analysis, and audiometric function testing. Demographic data, historical features, neurofibromatosis type 2 (NF2) status, initial testing results, and serial testing results were recorded.

RESULTS

An increase in tumor volume occurred in 14 of the 21 patients (66%). The pattern of volumetric change was found to be extremely variable. Multiple regression analysis revealed significant correlations of changes in tumor volume with changes in pure-tone average and speech discrimination score (P < .0001 and P = .0021, respectively). Change in tumor volume had greater effect on pure-tone average and speech discrimination score in patients initially with class D audiometric function when compared with those initially in class A (P = .0083 and P = .0245, respectively). The presence of NF2 had an independent protective effect against deterioration of the pure-tone average when compared with patients without NF2 (P = .0125).

CONCLUSIONS

This study demonstrated a significant correlation between a change in volume and auditory deterioration in vestibular schwannomas being managed with a trial of observation. A given change in tumor volume appeared to have a greater effect on pure-tone average and speech discrimination score as initial auditory classification declined.

摘要

目的

前瞻性地确定保守治疗的前庭神经鞘瘤肿瘤体积变化与听力功能之间的相关性。

研究设计

前瞻性纵向研究。

方法

1994年至1999年间,俄亥俄州立大学医院(俄亥俄州哥伦布市)的一项研究纳入了21例新诊断的前庭神经鞘瘤患者(年龄范围15 - 84岁;平均年龄63.3岁),以评估观察期内肿瘤体积与听力变化之间的相关性。患者每年接受临床检查、标准化的钆增强内耳道磁共振成像扫描以进行体积分析以及听力功能测试。记录人口统计学数据、病史特征、2型神经纤维瘤病(NF2)状态、初始测试结果和系列测试结果。

结果

21例患者中有14例(66%)肿瘤体积增大。发现体积变化模式极具变异性。多元回归分析显示肿瘤体积变化与纯音平均听阈变化和言语辨别得分变化显著相关(分别为P < .0001和P = .0021)。与最初听力分级为A类的患者相比,最初听力分级为D类的患者,肿瘤体积变化对纯音平均听阈和言语辨别得分的影响更大(分别为P = .0083和P = .0245)。与无NF2的患者相比,NF2的存在对纯音平均听阈恶化具有独立的保护作用(P = .0125)。

结论

本研究表明,在采用观察性试验治疗的前庭神经鞘瘤中,体积变化与听力恶化之间存在显著相关性。随着初始听力分级下降,肿瘤体积的给定变化似乎对纯音平均听阈和言语辨别得分有更大影响。

相似文献

1
Tumor growth and audiometric change in vestibular schwannomas managed conservatively.保守治疗的前庭神经鞘瘤的肿瘤生长及听力测定变化
Laryngoscope. 2000 Nov;110(11):1843-9. doi: 10.1097/00005537-200011000-00015.
2
Conservative management of vestibular schwannomas - second review of a prospective longitudinal study.前庭神经鞘瘤的保守治疗——一项前瞻性纵向研究的二次综述
Clin Otolaryngol Allied Sci. 2004 Oct;29(5):505-14. doi: 10.1111/j.1365-2273.2004.00852.x.
3
Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.神经纤维瘤病2型中双侧前庭神经鞘瘤生长与听力变化的一致性:神经纤维瘤病2型自然病史研究联盟
Otol Neurotol. 2009 Sep;30(6):835-41. doi: 10.1097/MAO.0b013e3181b2364c.
4
Are stage IV vestibular schwannomas preoperatively different from other stages?IV期前庭神经鞘瘤在术前与其他阶段有差异吗?
Otol Neurotol. 2008 Jan;29(1):46-9. doi: 10.1097/mao.0b013e31815c2a85.
5
A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. II. Audiological findings in 93 patients with unilateral vestibular schwannomas.单侧前庭神经鞘瘤患者及其家系的临床、遗传学和听力学研究。II. 93例单侧前庭神经鞘瘤患者的听力学研究结果
J Laryngol Otol. 1996 Dec;110(12):1120-8.
6
Trends in the management of vestibular schwannomas at Johns Hopkins 1997-2007.约翰霍普金斯大学 1997-2007 年前庭神经鞘瘤治疗趋势。
Laryngoscope. 2010 Jan;120(1):144-9. doi: 10.1002/lary.20672.
7
Consequences to hearing during the conservative management of vestibular schwannomas.前庭神经鞘瘤保守治疗期间的听力后果。
Laryngoscope. 2000 Feb;110(2 Pt 1):250-5. doi: 10.1097/00005537-200002010-00012.
8
Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.前庭神经鞘瘤的保守治疗:临床和生活质量结果的随访研究。
Otol Neurotol. 2009 Oct;30(7):968-74. doi: 10.1097/MAO.0b013e3181b4e3c9.
9
Conservative management of vestibular schwannomas: third review of a 10-year prospective study.前庭神经鞘瘤的保守治疗:一项10年前瞻性研究的第三次综述
Clin Otolaryngol. 2008 Jun;33(3):255-9. doi: 10.1111/j.1749-4486.2008.01705.x.
10
Hearing in patients with intracanalicular vestibular schwannomas.内耳道内前庭神经鞘瘤患者的听力情况
Audiol Neurootol. 2007;12(1):1-12. doi: 10.1159/000096152. Epub 2006 Oct 10.

引用本文的文献

1
Temporal Bone Magnetic Resonance Imaging in Sudden Sensorineural Hearing Loss: Low Frequency Versus Other Types.突发性感音神经性听力损失的颞骨磁共振成像:低频型与其他类型的比较
J Int Adv Otol. 2025 Mar 25;21(2):1-6. doi: 10.5152/iao.2025.241490.
2
Why Consider Aspirin for the Treatment of Vestibular Schwannoma? A Brief Review and Randomized, Double-Blind, Placebo-Controlled Study Proposal.为何考虑用阿司匹林治疗前庭神经鞘瘤?简要综述及随机双盲安慰剂对照研究方案。
Laryngoscope Investig Otolaryngol. 2025 Apr 1;10(2):e70121. doi: 10.1002/lio2.70121. eCollection 2025 Apr.
3
Sporadic Vestibular Schwannoma Size and Location Do not Correlate With the Severity of Hearing Loss at Initial Presentation.
散发性前庭神经鞘瘤的大小和位置与初次就诊时听力损失的严重程度无关。
Front Oncol. 2022 Mar 15;12:836504. doi: 10.3389/fonc.2022.836504. eCollection 2022.
4
The natural history of vestibular schwannoma growth-prospective 40-year data from an unselected national cohort.前庭神经鞘瘤生长的自然史——来自一个未选择的全国队列的40年前瞻性数据。
Neuro Oncol. 2021 May 5;23(5):827-836. doi: 10.1093/neuonc/noaa230.
5
Audiovestibular Loss of Function Correlates in Vestibular Schwannomas.前庭神经鞘瘤的听觉前庭功能丧失相关性
J Int Adv Otol. 2018 Aug;14(2):161-165. doi: 10.5152/iao.2018.5500.
6
Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.立体定向放射外科与分次放疗用于前庭神经鞘瘤患者肿瘤控制的系统评价
Acta Neurochir (Wien). 2017 Jun;159(6):1013-1021. doi: 10.1007/s00701-017-3164-6. Epub 2017 Apr 13.
7
Single Institutional Experience With Observing 564 Vestibular Schwannomas: Factors Associated With Tumor Growth.观察564例前庭神经鞘瘤的单机构经验:与肿瘤生长相关的因素
Otol Neurotol. 2016 Dec;37(10):1630-1636. doi: 10.1097/MAO.0000000000001219.
8
Progress of hearing loss in neurofibromatosis type 2: implications for future management.2型神经纤维瘤病听力损失的进展:对未来治疗的启示
Eur Arch Otorhinolaryngol. 2015 Nov;272(11):3143-50. doi: 10.1007/s00405-014-3317-7. Epub 2014 Oct 8.
9
Outcome on hearing and facial nerve function in microsurgical treatment of small vestibular schwannoma via the middle cranial fossa approach.经中颅窝入路显微手术治疗小型前庭神经鞘瘤的听力和面神经功能结果。
Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1209-16. doi: 10.1007/s00405-012-2074-8. Epub 2012 Jun 22.
10
Long-term outcomes of vestibular schwannomas treated with fractionated stereotactic radiotherapy: an institutional experience.采用分次立体定向放射治疗听神经鞘瘤的长期疗效:机构经验。
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):647-53. doi: 10.1016/j.ijrobp.2010.06.006. Epub 2010 Sep 29.